Viewing Study NCT06790966


Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2025-12-24 @ 4:32 PM
Study NCT ID: NCT06790966
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-11
First Post: 2025-01-14
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sponsor: PDS Biotechnology Corp.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module